Cytochrome P450 isoforms are differently up-regulated in aflatoxin B₁-exposed human lymphocytes and monocytes

References

• Olarte RA, Horn BW, Dorner JW, et al. Effect of sexual recombination on population diversity in aflatoxin production by Aspergillus flavus and evidence for cryptic heterokaryosis. Mol Ecol 2012;21:1453–1476
   PubMed Web of Science ®Google Scholar
• Chang PK, Scharfenstein LL, Mack B, et al. Deletion of the Aspergillus flavus Orthologue of A. nidulans fluG reduces conidiation and promotes production of sclerotia but does not abolish aflatoxin biosynthesis. Appl Environ Microbiol 2012;78:7557–7563
   PubMed Web of Science ®Google Scholar
• Donnelly PJ, Devereux TR, Foley JF, et al. Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice. Carcinogenesis 1996;17:1735–1740
   PubMed Web of Science ®Google Scholar
• Villar S, Ortiz-Cuaran S, Abedi-Ardekani B, et al. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis. PLoS ONE 2012;7:e37707
   Web of Science ®Google Scholar
• Josse R, Dumont J, Fautrel A, et al. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds. Toxicol Appl Pharmacol 2012;258:176–187
   PubMed Web of Science ®Google Scholar
• Jeannot E, Boorman GA, Kosyk O, et al. Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice. Int J Cancer 2012;130:1347–1356
   PubMed Web of Science ®Google Scholar
• Suphakarn VS, Newberne PM, Goldman M. Vitamin A and aflatoxin: effect on liver and colon cancer. Nutr Cancer 1983;5:41–50
   PubMedGoogle Scholar
• Dimitri RA, Gabal MA. Immunosuppressant activity of aflatoxin ingestion in rabbits measured by response to Mycobacterium bovis antigen I. Cell mediated immune response measured by skin test reaction. Vet Hum Toxicol 1996;38:333–336
   PubMedGoogle Scholar
• Ayed-Boussema I, Pascussi JM, Maurel P, et al. Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytes. Int J Toxicol 2012;31:86–93
   PubMed Web of Science ®Google Scholar
• Kensler TW, Roebuck BD, Wogan GN, et al. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci 2011;120 Suppl 1:S28–S48
   Web of Science ®Google Scholar
• Langouet S, Coles B, Morel F, et al. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res 1995;55:5574–5579
   PubMed Web of Science ®Google Scholar
• Bertilsson G, Heidrich J, Svensson K, et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 1998;95:12208–12213
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002;23:687–702
   PubMed Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102:1016–1023
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Drocourt L, Fabre JM, et al. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 2000;58:361–372
   PubMed Web of Science ®Google Scholar
• Teo YL, Saetaew M, Chanthawong S, et al. Effect of CYP3A4 inducer dexamethasone on hepatotoxicity oflapatinib: clinical and in vitro evidence. Breast Cancer Res Treat 2012;133:703–711
   PubMed Web of Science ®Google Scholar
• Binkhorst L, van Gelder T, Loos WJ, et al. Effects of CYP induction by rifampicin on tamoxifen exposure. Clin Pharmacol Ther 2012;92:62–67
   PubMed Web of Science ®Google Scholar
• Sumida A, Fukuen S, Yamamoto I, et al. Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR. Biochem Biophys Res Commun 2000;267:756–760
   PubMed Web of Science ®Google Scholar
• Klein PJ, Buckner R, Kelly J, et al. Biochemical basis for the extreme sensitivity of Turkeys to aflatoxin B1. Toxicol Appl Pharmacol 2000;165:45–52
   PubMed Web of Science ®Google Scholar
• Vrancic M, Banjanac M, Nujic K, et al. Azithromycin distinctively modulates classical activation of human monocytes in vitro. Br J Pharmacol 2012;165:1348–1360
   PubMed Web of Science ®Google Scholar
• Baron JM, Zwadlo-Klarwasser G, Jugert F, et al. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 1998;56:1105–1110
   PubMed Web of Science ®Google Scholar
• Krovat BC, Tracy JH, Omiecinski CJ. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol Sci 2000;55:352–360
   PubMed Web of Science ®Google Scholar
• van Duursen MB, Sanderson JT, van den Berg M. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol Sci 2005;85:703–712
   PubMed Web of Science ®Google Scholar
• Landi MT, Bertazzi PA, Baccarelli A, et al. TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident. Carcinogenesis 2003;24:673–680
   PubMed Web of Science ®Google Scholar
• Mary VS, Theumer MG, Arias SL, et al. Reactive oxygen species sources and biomolecular oxidative damage induced by aflatoxin B1 and fumonisin B1 in rat spleen mononuclear cells. Toxicol 2012;302:299–307
   PubMed Web of Science ®Google Scholar
• Mehrzad J, Klein G, Kamphues J, et al. In vitro effects of very low levels of aflatoxin B on free radicals production and bactericidal activity of bovine blood neutrophils. Vet Immunol Immunopathol 2011;141:16–25
   PubMed Web of Science ®Google Scholar
• Hassan Z, Khan MZ, Khan A, et al. Immunological status of the progeny of breeder hens kept on ochratoxin A (OTA)- and aflatoxin B(1) (AFB(1))-contaminated feeds. J Immunotoxicol 2012;9:381–391
   PubMed Web of Science ®Google Scholar
• Malvandi AM, Mehrzad J, Saleh-moghaddam M. Biologically relevant doses of mixed aflatoxins B and G up-regulate MyD88, TLR2, TLR4 and CD14 transcripts in human PBMC. Immunopharmacol Immunotoxicol 2013;35:528–532
   PubMed Web of Science ®Google Scholar
• Mehrzad J, Zhao X. T lymphocyte proliferative capacity and CD4+/CD8+ ratio in primiparous and pluriparous lactating cows. J Dairy Res 2008;75:457–465
   PubMed Web of Science ®Google Scholar
• Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271–279
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002--2007
   Web of Science ®Google Scholar
• Storvik M, Huuskonen P, Kyllonen T, et al. Aflatoxin B1-a potential endocrine disruptor up-regulates CYP19A1 in JEG-3 cells. Toxicol Lett 2011;202:161–167
   PubMed Web of Science ®Google Scholar
• Autrup H, Jorgensen EC, Jensen O. Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone. Mutagenesis 1996;11:69–73
   PubMed Web of Science ®Google Scholar
• Donnelly PJ, Stewart RK, Ali SL, et al. Biotransformation of aflatoxin B1 in human lung. Carcinogenesis 1996;17:2487–2494
   PubMed Web of Science ®Google Scholar
• Henderson MC, Miranda CL, Stevens JF, et al. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humuluslupulus. Xenobiotica 2000;30:235–251
   PubMed Web of Science ®Google Scholar
• Diaz GJ, Murcia HW, Cepeda SM. Cytochrome P450 enzymes involved in the metabolism of aflatoxin B1 in chickens and quail. Poultry Sci 2010;89:2461–2469
   PubMed Web of Science ®Google Scholar
• Kamdem LK, Meineke I, Gödtel-Armbrust U, et al. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. Chem Res Toxicol 2006;19:577–586
   PubMed Web of Science ®Google Scholar
• Murphy KP, Travers P, Walport M, et al. Janeway’s immunobiology. New York (NY): Garland Science; 2008
   Google Scholar
• Gallagher EP, Kunze KL, Stapleton PL, et al. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 1996;141:595–606
   PubMed Web of Science ®Google Scholar
• Jorge-Nebert LF, Jiang Z, Chakraborty R, et al. Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations. Hum Mutat 2010;31:27–40
   PubMed Web of Science ®Google Scholar
• Siest G, Jeannesson E, Marteau JB, et al. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab Dispos 2008;36:182–189
   PubMed Web of Science ®Google Scholar
• Ratajewski M, Walczak-Drzewiecka A, Salkowska A, et al. Aflatoxins upregulate CYP3A4 mRNA expression in a process that involves the PXR transcription factor. Toxicol Lett 2011;205:146–153
   PubMed Web of Science ®Google Scholar
• Nishimura M, Koeda A, Suganuma Y, et al. Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug Metab Pharmacokinet 2007;22:178–186
   PubMed Web of Science ®Google Scholar
• VandenHeuvel JP, Clark GC, Kohn MC, et al. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res 1994;54:62–68
   PubMed Web of Science ®Google Scholar
• Iber H, Chen Q, Sewer M, et al. Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Arch Biochem Biophys 1997;345:305–310
   PubMed Web of Science ®Google Scholar
• Messina A, Nannelli A, Fiorio R, et al. Expression and inducibility of CYP1A1, 1A2, 1B1 by beta-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig. Toxicol 2009;260:47–52
   PubMed Web of Science ®Google Scholar
• Wu Y, Shi X, Liu Y, et al. Histone deacetylase 1 is required for carbamazepine-induced CYP3A4 expression. J Pharm Biomed Anal 2012;58:78–82
   PubMed Web of Science ®Google Scholar
• Chaytor AC, See MT, Hansen JA, et al. Effects of chronic exposure of diets with reduced concentrations of aflatoxin and deoxynivalenol on growth and immune status of pigs. J Anim Sci 2011;89:124–135
   PubMed Web of Science ®Google Scholar